Agios Pharmaceuticals, Inc. (AGIO)
31.80
-0.68
(-2.09%)
USD |
NASDAQ |
Oct 02, 16:00
31.82
+0.02
(+0.06%)
After-Hours: 20:00
Agios Pharmaceuticals Net Income (Quarterly) : -100.70M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -100.70M |
| March 31, 2026 | -99.11M |
| December 31, 2025 | -108.04M |
| September 30, 2025 | -103.43M |
| June 30, 2025 | -112.02M |
| March 31, 2025 | -89.29M |
| December 31, 2024 | -96.52M |
| September 30, 2024 | 947.92M |
| June 30, 2024 | -96.12M |
| March 31, 2024 | -81.55M |
| December 31, 2023 | -95.94M |
| September 30, 2023 | -91.32M |
| June 30, 2023 | -83.81M |
| March 31, 2023 | -81.02M |
| December 31, 2022 | 36.53M |
| September 30, 2022 | -81.75M |
| June 30, 2022 | -91.81M |
| March 31, 2022 | -94.77M |
| December 31, 2021 | -98.58M |
| September 30, 2021 | -84.26M |
| June 30, 2021 | -82.79M |
| March 31, 2021 | -90.88M |
| December 31, 2020 | -84.54M |
| September 30, 2020 | -79.18M |
| June 30, 2020 | -81.50M |
| Date | Value |
|---|---|
| March 31, 2020 | -84.09M |
| December 31, 2019 | -102.35M |
| September 30, 2019 | -106.17M |
| June 30, 2019 | -109.87M |
| March 31, 2019 | -93.08M |
| December 31, 2018 | -91.79M |
| September 30, 2018 | -94.66M |
| June 30, 2018 | -68.74M |
| March 31, 2018 | -90.82M |
| December 31, 2017 | -88.28M |
| September 30, 2017 | -77.14M |
| June 30, 2017 | -83.08M |
| March 31, 2017 | -66.17M |
| December 31, 2016 | -56.49M |
| September 30, 2016 | -62.83M |
| June 30, 2016 | -55.95M |
| March 31, 2016 | -23.20M |
| December 31, 2015 | -40.62M |
| September 30, 2015 | -40.26M |
| June 30, 2015 | -31.90M |
| March 31, 2015 | -4.957M |
| December 31, 2014 | -26.66M |
| September 30, 2014 | 3.704M |
| June 30, 2014 | -18.30M |
| March 31, 2014 | -12.25M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Biogen, Inc. | 97.50M |
| Insmed, Inc. | -13.24M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Regeneron Pharmaceuticals, Inc. | 1.297B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 44.74M |
| Total Expenses (Quarterly) | 145.45M |
| EPS Diluted (Quarterly) | -1.693 |
| Enterprise Value | 1.309B |
| Gross Profit Margin (Quarterly) | 90.29% |
| Profit Margin (Quarterly) | -225.1% |
| Earnings Yield | -22.04% |
| Normalized Earnings Yield | -22.04 |